Immune Tolerance Clinical Trial
Official title:
Quorum Sensing Signal Molecules (QSSMs) and Immune Dysfunction in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) for Obstructive Jaundice
Patients with obstructive jaundice (OJ) often require surgical, endoscopic or radiological interventions to facilitate biliary drainage and relieve jaundice. However it is known that patients with OJ have increased surgical risks than non-jaundiced patients undergoing the same procedures. Surgery for severe OJ is associated with a significant post-operative mortality (10-15%) and morbidity (30-65%). The commonest complications are related to sepsis but the pathophysiological mechanisms behind this susceptibility to bacterial infection are not clear. Recent work has shown a pivotal role of bile in the maintenance of enterocyte tight junctions and the expression of tight junction-associated proteins which could account for the translocation of enteric bacteria and bacterial products to mesenteric lymph node complexes, the portal circulation and subsequently the liver. Some of these bacterial products, such as endotoxin and quorum sensing signalling molecules (QSSMs), have immunomodulatory properties which may dampen normal immune responses to infection resulting in life-threatening organ dysfunction. Bacterial endotoxin and quorum sensing signalling molecules (QSSMs) represent good candidates for the mediators of this immune suppression and although there is a compelling case for their involvement in the pathogenesis of sepsis, evidence to support their involvement in the aetiology of infection in OJ is currently lacking.
Obstructive jaundice (OJ) is a condition where a blockage of flow of bile from the liver
leads to the accumulation of bile products in the blood resulting in yellowing and itching
of the skin. Common causes of OJ include gallstones and also tumours of the pancreas or bile
duct. Relieving this type of jaundice and treating the underlying cause can include
endoscopic or surgical procedures. It is known however, that patients with OJ have increased
surgical risks than non-jaundiced patients who undergo the same operations. Studies have
shown that surgery for severe OJ is associated with a postoperative mortality in the region
of 10-15% and morbidity rates of 30-65%. Complications related to bacterial infection are
common and patients developing severe infections may require treatment with broad spectrum
antibiotics with care in intensive or high dependency units.
Although antibiotics have proved invaluable in treating postoperative infections they carry
the potential for adverse effects. Antibiotics can suppress normal gut bacteria and allow
disease causing bacteria to proliferate, such as Clostridium difficile. This usually
manifests as mild-to-moderate diarrhoea but can occasionally cause life-threatening bowel
inflammation. The widespread use of antibiotics is also central to the development of
bacterial strains with antibiotic resistance. This clinical problem also has economic,
political and environmental implications for the National Health Service. Adherence to
measures of infection control, education and antibiotic policy can minimise antibiotic
resistance; however the limits surrounding such approaches have led to a demand for novel or
alternative strategies.
It has recently been discovered that bacteria are able to communicate by producing
specialised molecules known as quorum sensing signalling molecules (QSSMs). An accumulation
of QSSMs in their surrounding environment allow for the bacteria to quantify the size of
colonies. At specific colony sizes the concentration of QSSMs reaches a critical threshold
leading to the activation of genes that cause an infection. Disruption of quorum sensing has
been shown to reduce the severity of infection in animal studies and this has led to the
development of inhibitors of quorum sensing as a possible strategy in antibacterial therapy.
Previous work conducted at the University of Nottingham has demonstrated that QSSMs also
influence the number and function of a specific type of immune cell known as 'antigen
presenting cells'. These cells are pivotal in allowing the immune system to recognise
components of bacteria as foreign and thereby mount the appropriate response. It was found
that large numbers of these types of cells underwent programmed cell death (cell suicide) in
the presence of QSSMs compared to when QSSMs were absent. This mirrors the situation in
blood sampled from patients with severe infections where there is a greater proportion of
cell deaths among antigen presenting cells than other types of immune cell.
It is likely that the susceptibility to infectious complications in patients with
obstructive jaundice is due to the interplay of various factors. The absence of intestinal
bile has implications for the integrity of the bowel wall as a barrier, changes in gut
microflora flora and translocation of both bacteria and their products. In addition, it is
clear that a form of immune dysfunction occurs, which dampens the normal response following
exposure to bacterial products. This immune dysfunction may avert powerful inflammatory
cascades resulting in life-threatening multi organ dysfunction but at the expense of
conditions that favour bacterial survival. QSSMs represent good candidates for the mediators
of this immune dysfunction and although there is a compelling case for their involvement in
the pathogenesis of sepsis, definitive evidence to support their role in infective processes
in OJ is currently lacking.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04621916 -
Preventing Inhibitor Recurrence Indefinitely
|
Phase 4 | |
Recruiting |
NCT06243289 -
Improving KIdney Transplantation With Cellular Therapy Study
|
||
Recruiting |
NCT03591302 -
Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.
|
Phase 1 | |
Completed |
NCT04525456 -
Immune Responses With Reduxium
|
N/A | |
Recruiting |
NCT04314518 -
The Correlation Between Immunological Reaction of the Seminal Fluid in the Mother's Blood and Pregnancy Complications
|
||
Enrolling by invitation |
NCT04571203 -
Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
|
Phase 1 | |
Enrolling by invitation |
NCT01117077 -
The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis
|
N/A | |
Terminated |
NCT05010174 -
Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products
|
||
Active, not recruiting |
NCT03744325 -
Immune Responses in Hen's Egg Oral Immunotherapy
|
N/A | |
Completed |
NCT03383211 -
Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers
|
||
Recruiting |
NCT02861872 -
Intra-peritoneal Chemotherapy in Ovarian Cancer
|
N/A | |
Active, not recruiting |
NCT00319657 -
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
|
Phase 1/Phase 2 | |
Completed |
NCT01538485 -
Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT
|
Phase 4 | |
Completed |
NCT03393793 -
HEart trAnsplantation Registry of piTie-Salpetriere University Hospital
|
||
Completed |
NCT01996774 -
Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance
|
N/A | |
Recruiting |
NCT03292445 -
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
|
Early Phase 1 | |
Active, not recruiting |
NCT05745792 -
Clinico-immunological Characterization and Immune Tolerance Breakdown in HU-autoimmunity
|
||
Completed |
NCT02642237 -
The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response
|
N/A | |
Completed |
NCT01414504 -
Pneumococcal Conjugate Vaccine Followup
|
Phase 2 | |
Not yet recruiting |
NCT06147375 -
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
|
N/A |